Online citations, reference lists, and bibliographies.
← Back to Search

Tumor Necrosis Factor-alpha Eliminates Binding Of NF-Y And An Octamer-binding Protein To The Lipoprotein Lipase Promoter In 3T3-L1 Adipocytes.

C. Morin, I. Schlaepfer, R. Eckel
Published 1995 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
TNF alpha has been shown to reduce lipoprotein lipase (LPL) activity in adipose tissue. Regulation of LPL by TNF alpha occurs at the level of LPL gene transcription and posttranscriptionally. To elucidate further the transcriptional mechanism of TNF alpha inhibition of LPL gene transcription, transfection analysis was used to locate the site(s) of the LPL promoter that imparts the TNF alpha response. Transient transfections using LPL promoter deletions fused to luciferase in differentiated 3T3-L1 cells with and without TNF alpha treatment indicated that a DNA region downstream of -180 bp confers the TNF alpha effect. Electrophoretic mobility shift assays using two 32P-labeled LPL probes spanning the region between -180 and +44 bp revealed the loss of several LPL DNA-protein interactions after TNF alpha treatment, including the binding of NF-Y to the CCAAT box and a protein to the octamer consensus sequence. Protein binding to the OCT-1 consensus sequence is unaffected until after 4 h of TNF alpha treatment. In addition, the amount of mRNA for OCT-1 is not altered with TNF alpha treatment. These results indicate that TNF alpha regulates at least two DNA-binding proteins on the proximal promoter, thereby inhibiting LPL gene transcription.



This paper is referenced by
10.1194/JLR.R200015-JLR200
Lipoprotein lipase: genetics, lipid uptake, and regulation.
M. Merkel (2002)
10.2217/clp.12.71
Unraveling the role of nicotinamide phosphoribosyltransferase on lipids in atherosclerosis
Tuva B. Dahl (2012)
10.3390/cells9071596
Exploring Therapeutic Targets to Reverse or Prevent the Transition from Metabolically Healthy to Unhealthy Obesity
Tenzin D Dagpo (2020)
10.3109/10409238.2011.628970
NF-Y and the transcriptional activation of CCAAT promoters
D. Dolfini (2012)
10.1046/J.1365-2168.1996.02445.X
Sepsis and fat metabolism
J. Samra (1996)
Obesity and Diabetes in TNF-a Receptor – deficient Mice
S. Schreyer (1998)
10.1152/AJPENDO.00562.2003
Nonexercise activity thermogenesis (NEAT): environment and biology.
J. Levine (2004)
Transcription factors CCAAT/enhancer-binding protein beta and nuclear factor-Y bind to discrete regulatory elements in the very low density lipoprotein receptor promoter.
R. Kreuter (1999)
10.1038/OBY.2000.20
Tumor necrosis factor-alpha stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: promotion of adipose tissue expansion by paracrine growth factors.
K. Kras (2000)
10.1006/ABBI.1998.0982
Endothelin-stimulated Ca2+ mobilization by 3T3-L1 adipocytes is suppressed by tumor necrosis factor-alpha.
M. Yorek (1999)
10.1016/S1262-3636(07)70104-0
Polymorphism of stress protein HSP70-2 gene in Tunisians: susceptibility implications in type 2 diabetes and obesity.
K. Zouari Bouassida (2004)
10.1016/j.ejphar.2019.172492
Epigenetic regulation of lipoprotein lipase gene via BRD4, which is potentially associated with adipocyte differentiation and insulin resistance.
T. Inoue (2019)
10.1310/sci2303-175
Exercise and Health-Related Risks of Physical Deconditioning After Spinal Cord Injury.
Jennifer L. Maher (2017)
Susceptibilidad genética a la cirrosis
I. Rojas (2005)
10.1097/00041433-200210000-00002
Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism
Karina Preiss-Landl (2002)
10.1093/GERONA/52A.4.B190
Adipose Tissue-Derived Tumor Necrosis Factor-α Activity Is Elevated in Older Rats
C. Morin (1997)
10.1152/AJPREGU.1997.273.2.R683
Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase.
D. R. Jensen (1997)
10.1016/S0378-1119(99)00368-6
The molecular biology of the CCAAT-binding factor NF-Y.
Roberto Mantovani (1999)
10.1172/JCI2849
Obesity and diabetes in TNF-alpha receptor- deficient mice.
S. Schreyer (1998)
SHORT COMMUNICATION Tumor necrosis factor-a7308 G=A polymorphism in obese Caucasians
E. Brand (2001)
10.1038/sj.ijo.0801576
Tumor necrosis factor-α−308 G/A polymorphism in obese Caucasians
E. Brand (2001)
Characterisation of the tumour necrosis factor (TNF)-(alpha) response elements in the human ICAM-2 promoter.
F. Mclaughlin (1999)
Quantifying Serum TNF-Alpha Cut-Off Point for Predicting Coronary Stenosis Severity in a Population from Northern Iran
Bijan Shad (2014)
10.1152/ajpendo.90920.2008
Lipoprotein lipase: from gene to obesity.
H. Wang (2009)
10.1155/2012/398697
Lipoprotein Lipase as a Candidate Target for Cancer Prevention/Therapy
S. Takasu (2012)
Sp1 and Sp3 transactivate the human lipoprotein lipase gene promoter through binding to a CT element: synergy with the sterol regulatory element binding protein and reduced transactivation of a naturally occurring promoter variant.
W. Yang (1998)
Role of immune mediators in metabolic syndrome and atherosclerosis
D. Strodthoff (2013)
10.1016/j.atherosclerosis.2014.10.016
Lipoprotein lipase: from gene to atherosclerosis.
Y. Li (2014)
10.1016/J.AQUACULTURE.2014.10.030
Tumor necrosis factor alpha is a potent regulator in fish adipose tissue
D. Liu (2015)
10.1007/s10695-018-0502-4
Molecular cloning of adipose triglyceride lipase (ATGL) gene from blunt snout bream and its expression after LPS-induced TNF-α factor
Yong-jun Dai (2018)
10.1007/s00109-002-0384-9
Lipoprotein lipase: structure, function, regulation, and role in disease
J. R. Mead (2002)
10.1194/jlr.M600510-JLR200
Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages Published, JLR Papers in Press, July 20, 2007.
Guosong Qiu (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar